Description
An innovative solution for weight and diabetes management
Semaglutide, marketed under the names Ozempic and Wegovy, is a member of the GLP-1 family. It helps regulate blood sugar and control appetite by mimicking the body’s natural hormone.
What’s the difference between Ozempic and Wegovy?
- Ozempic: Used mainly to treat type 2 diabetes and reduce cardiovascular risk.
- Wegovy: Specially designed for weight loss and reducing obesity-related complications.
How does Sema/Wego promote weight loss?
They act directly on the brain receptors that control hunger. It slows digestion, prolongs the feeling of satiety and helps reduce calorie consumption naturally.
What are the side effects?
The most common effects are mild to moderate digestive disorders such as nausea, diarrhea, constipation and vomiting, which generally diminish over time.
The benefits
- Appetite reduction for better food control
- Progressive, lasting weight loss
- Stabilizes blood sugar levels by promoting insulin release
- Reducing cardiovascular risk
